HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Robin G. Cummings James E. Lowe Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leung, C. Y. Articles by Lowe, J. E. Search for Related Content PubMed PubMed Citation Articles by Leung, C. Y. Articles by Lowe, J. E.

Ann Thorac Surg 1988;45:291-295
© 1988 The Society of Thoracic Surgeons

---

Articles

Chondrosarcoma Metastatic to the Heart

From the Departments of Surgery and Pathology, Duke University Medical Center, Durham, NC

Accepted for publication October 15, 1987.

^* Address reprint requests to Dr. Lowe, Duke University Medical Center, PO Box 3954, Durham, NC 27710

This review summarizes the clinical manifestations and results of treatment of chondrosarcoma metastatic to the heart. Including the patient in the present report, a total of 18 patients have been reported. The most common site of cardiac metastasis was the right atrium. Dyspnea and pleuritic chest pain were the most common symptoms associated with cardiac metastases. The median time from the initial diagnosis of primary chondrosarcoma to death was 36 months, and the median time from the initiation of cardiac symptoms to death was 2 months. Treatment of primary chondrosarcoma included local radical resection in 14 patients. Treatment of cardiac metastases consisted of palliative support in 13 patients and surgical resection in 5 patients. Median survival following the development of cardiac symptoms was 2 months for patients treated nonsurgically and 18 months for those who underwent resection of cardiac metastases. The longest survival (24 and 28 months) was obtained in 2 patients with metastases confined to the heart that were successfully resected soon after development of cardiac symptoms. These results suggest that surgical resection of cardiac metastases in patients without widespread other metastases can result in substantial prolongation of life.

This article has been cited by other articles:

				C. Parmar, A. Jojo, K. C. Vachhani, and S. N. Vijayan Primary chondrosarcoma of the heart Eur J Cardiothorac Surg, March 1, 2008; 33(3): 512 - 514. [Abstract] [Full Text] [PDF]

				C.-H. Yap, C. Hair, S. Foy, S. Sewak, M. Francis, and J. F Kenny Resection of Right Atrial Metastatic Large-Cell Neuroendocrine Carcinoma Asian Cardiovasc Thorac Ann, February 1, 2007; 15(1): e20 - e22. [Abstract] [Full Text] [PDF]

				K. Z'graggen, C. Fernandez-del Castillo, D. W. Rattner, H. Sigala, and A. L. Warshaw Metastases to the Pancreas and Their Surgical Extirpation Arch Surg, April 1, 1998; 133(4): 413 - 418. [Abstract] [Full Text] [PDF]